May 7, 2018 / 1:03 PM / 6 months ago

BRIEF-Nymox Announces Relocation Of Company Headquarters To Switzerland

Nymox Pharmaceutical Corp:

* NYMOX ANNOUNCES RELOCATION OF COMPANY HEADQUARTERS TO SWITZERLAND

* NYMOX PHARMACEUTICAL CORP - INITIATED PROCESS OF RELOCATING COMPANY HEADQUARTERS FROM NASSAU, BAHAMAS TO ZUG IN SWITZERLAND

* NYMOX PHARMACEUTICAL CORP - PREPARING FOR SCALE-UP & COMMERCIALIZATION FOR FEXAPOTIDE TRIFLUTATE AS A COMPLETELY NEW TREATMENT OPTION

* NYMOX PHARMACEUTICAL - COMMERCIALIZATION FOR FEXAPOTIDE TRIFLUTATE FOR MEN SUFFERING FROM PROSTATE PROBLEMS ASSOCIATED WITH AGING & PROSTATE ENLARGEMENT

* NYMOX PHARMACEUTICAL CORP - EXPECTS TO REPORT ON EUROPEAN REGULATORY REVIEW PROCESS BY END OF Q3 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below